Navigation Links
ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma
Date:12/22/2011

rmation about Meritage Pharma is available at www.meritagepharma.com.

Meritage™ is a trademark of Meritage Pharma, Inc.

Disclosure Notice

Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide our current expectations or forecasts of future events, including the therapeutic indication and use, safety, efficacy, tolerability and potential of oral budesonide suspension (OBS) as a treatment for Eosinophilic Esophagitis (EoE) and the ability of Meritage to develop OBS and execute on its plans including clinical development activities with OBS related to EoE; whether ViroPharma ultimately will acquire Meritage; anticipated scientific progress on the OBS research program; and the relative value to ViroPharma's business of an acquisition of Meritage. There can be no assurance that that the clinical program with OBS will yield positive results or support further development of OBS for EoE. The FDA may view the data regarding utilization of OBS for EoE as insufficient or inconclusive, request additional data, require additional clinical studies, delay any decision past the time frames anticipated by us, limit any approved indications. These factors, and other factors, including, but not limited to those described in our annual report on Form 10-K for the year ended December 31, 2010 and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission for the periods ended March 31, 2011, June 30, 2011 and September 30, 2011, could cause future results to differ materially from the expectations expressed in this press release. The forward-looking statements contained in this press release are made as of the date hereof and may become outdated over time. ViroPharma does not assume any responsibility for updating any forward-looking statements. These forward looking statem
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... DUBLIN , May 21, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/5x377m/north_american ) has announced the addition of ... by Type (Ankle Replacement, Digit Replacement, Elbow ... - Forecast to 2019" report to ... market for knee replacement was valued at ...
(Date:5/21/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/6csvbs/market_assessment ... "Market Assessment of Respiratory Diagnostics in the United ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,This research service provides ... in the United States ... provides detailed analysis of the current and forecasted ...
(Date:5/21/2015)... May 21, 2015  Cardica, Inc. (Nasdaq: CRDC ) ... Greg Watson , the company,s vice president of operations, was ... common stock, at a per share exercise price of $0.43, ... option was granted pursuant to Cardica, Inc.,s Inducement Plan, which ... 2015 under Rule 5653(c)(4) of the Nasdaq Global Market for ...
Breaking Medicine Technology:North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2United States and Europe Respiratory Diagnostics Market Assessment 2015 2Cardica Announces New Employment Inducement Grant 2
... Reportlinker.com announces that a new ... its catalogue: Hip ... Landscape and Market Forecasts to 2017 ... Hip Resurfacing Implants - ...
... -- China Medical Technologies, Inc. (the "Company") (Nasdaq: ... in-vitro diagnostic ("IVD") company, today announced that its ... ("Beijing Yuande") has  passed the examination by the ... new technology enterprise status for another three year ...
Cached Medicine Technology:Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 13China Medical Technologies Announces the Approval of the Renewed High and New Technology Enterprise Status for a Major Subsidiary in China 2
(Date:5/22/2015)... Yisrayl Hawkins, Pastor and Overseer at The House ... calling on religious leaders to make changes in order to ... his blog, discusses the history of war, how it started, ... Yisrayl says mankind was created to lead peaceful, joyful lives, ... , “Yahweh created mankind, according to His Plan, which ...
(Date:5/22/2015)... 2015 Pro3rd Impression is ... for Final Cut Pro X. Pro3rd Impression's clean and ... , Intuitive on-screen-controls allow users to customize scale, position ... layouts, and much more can be edited using the ... Pro3rd Impression comes packed with 30 simplistically elegant ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 World Patent ... products, launches the Troll Motor Guide, a boat patent ... boating. , "The recreational boating industry has reached an ... CEO and Creative Director of World Patent Marketing ... numbers and predicts continued steady growth of seven percent ...
(Date:5/21/2015)... 2015 WellCare Health Plans, Inc. (NYSE: WCG) ... by the Florida Healthy Kids Corporation (FHKC) to continue to ... as part of the Florida Healthy Kids (FHK) program. Pending ... and may be extended for two additional years at FHKC’s ... in the FHK program who live in Regions 1, 2, ...
(Date:5/21/2015)... 2015 The Johns Hopkins Alliance for ... Baltimore Commercial Advisory Board has selected a research project ... as one of two $50,000 Abell Foundation Award for ... known as Anklebot. Developed by the VA Maryland ... the University of Maryland School of Medicine and Massachusetts ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Calls on All Religions to Wake Up and Make Drastic Changes to End Suffering in New Letter 2Health News:Developers at Pixel Film Studios Release Pro3rd Impression for Final Cut Pro X. 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3Health News:WellCare Selected to Continue Participating in the Florida Healthy Kids Program, Will Serve Nine Florida Regions Under the New Contract 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 3
... treatments, researchers say, , WEDNESDAY, June 10 (HealthDay News) ... increase the risk of developing primary biliary cirrhosis, a ... biliary cirrhosis is an autoimmune disorder that blocks the ... that mostly affects women, striking about one in 2,500 ...
... ISRAEL, June 10, 2009 Metoclopramide, a drug approved in ... risks for the fetus according to a large cohort study ... New England Journal of Medicine , "The Safety of Metoclopramide ... J Med 2009;360:24 June 11, 2009). According to ...
... for America,s Health (TFAH) today applauded the U.S. Senate Committee ... prevention and public health components in the Affordable Health Choices ... , "Our nation will never be able to contain health ... Americans healthier and preventing disease," said Jeff Levi, Ph.D., Executive ...
... Lack of Reimbursement for Nutrition Services Is Key Barrier , ... care physicians believe the nation,s health care system should place ... according to a new survey released today. However, only 12 ... the context of chronic disease. , , "The ...
... at The Wistar Institute have defined a key target ... of aging. The study, published June 11 in ... aging that could point toward new anti-aging strategies and ... a class of proteins called sirtuins promotes fitness and ...
... Media Associates, LLC, a full-service video content marketing firm here, has ... , ACW recognized RPD Media for producing: an online video podcast ... a radio spot series for WHUD entitled ... a feature film for The Snowball Gala for the Boys ...
Cached Medicine News:Health News:Genetic Links to Rare Liver Disease Found 2Health News:Genetic Links to Rare Liver Disease Found 3Health News:Off-label morning sickness drug deemed safe for fetuses -- Ben-Gurion U. researchers 2Health News:TFAH Applauds 'Affordable Health Choices Act' for Making Prevention a Cornerstone of Health Reform 2Health News:TFAH Applauds 'Affordable Health Choices Act' for Making Prevention a Cornerstone of Health Reform 3Health News:TFAH Applauds 'Affordable Health Choices Act' for Making Prevention a Cornerstone of Health Reform 4Health News:More Than 9 in 10 Primary Care Physicians Say U.S. Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 2Health News:More Than 9 in 10 Primary Care Physicians Say U.S. Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 3Health News:More Than 9 in 10 Primary Care Physicians Say U.S. Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 4Health News:Wistar Institute team finds key target of aging regulator 2Health News:RPD Media Wins Four 'Big W' Awards by the Advertising Club of Westchester County 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: